10,433 Results

Data from RELEASE-1 and RELEASE-2 phase III studies of collagenase clostridium histolyticum presented by Endo Pharma at The Aesthetic Society meeting.

 Added 1 day ago

Endo International plc announced that clinical data from a Phase III investigational study of collagenase clostridium histolyticum (CCH) for the...

Updated data on PLEDGE program of relamorelin to treat diabetic gastroparesis.- Allergan

 Added 1 day ago

Allergan plc announced the expansion of the PLEDGE program with a fifth study now evaluating relamorelin, an investigational, ghrelin agonist...

New data for larotrectinib to treat children with TRK fusion cancer. - Bayer

 Added 1 day ago

Bayer has announced findings from new analyses for larotrectinib, showing an overall response rate (ORR) of 94% in children with...

First patient enrolled in phase III clinical trial of fostamatinib to treat warm antibody autoimmune hemolytic anemia .- Rigel Pharma

 Added 2 days ago

Rigel Pharmaceuticals, Inc. announced that it has enrolled the first patient in a pivotal Phase III clinical trial of fostamatinib...

FDA advisory committee does not recommend approval for AC 220 in acute myeloid leukemia.- Daiichi Sankyo

 Added 2 days ago

The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 8 to 3 against approving an NDA for AC 220 (quizartinib), from...

European Commission approves triplet therapy (pomalidomide + bortezomib + dexamethasone) for multiple myeloma.- Celgene Corporation

 Added 2 days ago

Celgene Corporation announced that the European Commission (EC) has approved two new triplet regimens based on Celgene’s proprietary IMiD treatments,...

European Commision approval for Revlimid + bortezomib + dexamethasone indicated for the treatment of patients with previously untreated multiple myeloma . Celgene Corporation

 Added 2 days ago

Celgene Corporation announced that the European Commission (EC) has approved two new triplet regimens based on Celgene’s proprietary IMiD treatments,...

Phase III pivotal study of PF 04965842 shows efficacy and safety in atopic dermatitis.- Pfizer

 Added 3 days ago

Pfizer announced positive top-line results from a Phase III pivotal study (B7451012) evaluating the efficacy and safety of its investigational...

REVERSE Phase III trial of GS 010 shows improvement in Leber Hereditary Optic Neuropathy.- GenSight Biologics

 Added 3 days ago

GenSight Biologics reported a first set of results from Week 96 of the REVERSE Phase III clinical trial of GS...

FDA requires new phase III trial for mirvetuximab soravtansine for patients with (FR alpha)-positive, platinum-resistant ovarian cancer. ImmunoGen Inc.

 Added 3 days ago

ImmunoGen, Inc.,has announced the FDA has recommended that the Company conduct a new Phase III randomized trial to evaluate the...

Load more